megan

megan 25 10 月, 2024

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - October 24, 2024) - Military Metals Corp. (CSE: MILI) (OTC Pink: MILIF) (FSE: QN90) (the "Company" or "Military") announces it has signed a binding LOI to acquire further claims surrounding its West Gore Antimony Project ("West Gore" or the "Project") to consolidate the mineralized area. West Gore is a brownfield project with past production, historical high-grade drill results include 7.07 metres of 10.6 gpt gold and 3.4% antimony. During a period of production, it was Canada's most prominent antimony mine.West Gore consists of four Exploration Licenses comprising 585 hectares located in Hants County, Nova Scotia, Canada, and the newly acquired ground adds 388 hectares to the immediate northwest of the Project, comprising the balance of the West Gore antimony-gold mineralized system and its historical mine workings. The Company has a three-year option to acquire a 100% interest in the licenses for $235,000 spread over the term and the sellers will receive a 3% Net Smelter Royalty ("NSR") with standard buy-back provisions. It is anticipated the Company will announce the Definitive Agreement within ten days.The historical West Gore mines have a mining history dating back to 1883 and were a significant source of antimony during the First World War, most of which was shipped to England. Total production of gold and antimony between 1883 and 1917, the last recorded year of production, remains unknown. However, between 1914 and 1917 alone, nearly 32,000 metric tons were mined yielding over 7,000 metric tons of antimony concentrate grading 46% antimony. The total amount of gold recovered up to 1917 was estimated to be nearly 6,900 ounces. Aside from minor exploration work in the 1960s, the 1980s, and again over the past few years, the West Gore system remains essentially unexplored.With the acquisition of the new claims the Company has gained complete coverage over the entire mineralized system including all the historical mine workings and known antimony-gold occurrences with additional ground along trend in both directions as exhibited in Map 1 below. This in turn enables the Company to approach this antimony-gold system in its entirety to unlock future value. All relevant data are in the process of being compiled into an integrated digital database, with exploration plans to follow.Map 1: West Gore Project ClaimsTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/227668_841965127489abc4_001full.jpgAntimony-gold mineralization at West Gore is hosted in graphitic and sulfide-bearing slates of the lower units of the Cambrian-age Halifax Formation that were deformed into a northeast-trending, upright, closed syncline and metamorphosed to greenschist facies during the regional Acadian orogeny. Mineralization occurs as stibnite, native antimony, aurostibnite, and antimony-gold alloys and oxides. Whereas the fold belt strikes northeast-southwest, mineralized structures trend northwest-southeast.The technical contents of this release were reviewed and approved by Avrom E. Howard, MSc, PGeo, geological consultant to Military Metals and a qualified person as defined by National Instrument 43-101.Investor Relations EngagementOn October 23, 2024, the Company engaged Clarkham Capital ("Clarkham") to provide investor relations services with a focus on the German stock market and the German-speaking investment community in support of the company listing on the Frankfurt Stock Exchange (the "Clarkham Agreement"). Pursuant to the terms of the Clarkham Agreement, Clarkham will, among other items, provide the Company with marketing services, which includes social media management, content creation, distribution, digital marketing, including, but not limited to, the preparation of articles and coverages on multiple financial platforms and newsletters, and translation and distribution of press releases in Germany and any other marketing services as agreed upon by the Company and Clarkham (the "Services"). The Clarkham Agreement has a term of two (2) months and is anticipated to commence on or about October 24, 2024. The Company will make a one-time payment to Clarkham of EUR 200,000 (CAD$298,340), as consideration for the Services. Sebastian Korbach will be providing the Services to the Company on behalf of Clarkham and may be contacted at +44-20-38839398 or cc@clarkham.com, or Flat 285, 61 Praed Street, London, UK W2 1ns. The Company will not issue any securities to Clarkham as compensation. Both Clarkham and Sebastian Korbach are arm's length to the Company and do not have any interest, direct or indirect, in the Company or its securities nor do they have any right to acquire such an interest.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD OF DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-Looking information in this news release includes statements related to the completion of the acquisition of the Target by Military, as well as future plans for exploration activities, and assumptions related to the continuation of the global demand for antimony. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include entry into a definitive agreement in respect of the Acquisition, meeting the conditions to close the Acquisition, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subjects of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both the Acquisition and any future activities in respect of the properties held by the Target. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-Looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227668 Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

TOKYO, October 25, 2025 - (ACN Newswire via SeaPRwire.com) - Kryterion Inc. announces the expansion of its Japan operations in an exciting move that will extend its software as a service (SaaS) certification and assessment software services for new and existing clients headquartered in Japan, reinforcing its commitment to client service excellence."Kryterion is set to be a premier provider of Japanese-language test delivery and locally staffed support services in Japan and for the international community," says William Dorman, Kryterion Chairman. "Simultaneously, we will introduce our highly secure, computer-based assessment management services to Japanese organizations serving the dynamic Japanese marketplace and the wider international community. Kryterion has a proven track record in transitioning from paper-based testing to computer-based testing and from onsite computer-based testing to secure, internet-based, proctored testing."Kryterion is a leading SaaS digital test development and test delivery provider in international markets, with approximately 1000 test center affiliates. It introduced secure, online proctored (OLP) exam delivery with a lockdown browser in 2007 and today provides global assessment services support, including Japanese language testing in Japan. Kryterion a subsidiary of the Drake International Group, which, through its subsidiaries, possesses a presence in 13 countries, including Japan, Korea, Taiwan, Hong Kong, Singapore, the Philippines, New Zealand, and Australia. Currently, Drake International's largest subsidiary in Japan is Drake Business Services Asia (DBSA). Led by CEO Grant Mackenzie, the company has been active in Japan since 2017. DBSA is a leading managed services provider, offering complete outsourced management of non-core support functions to deliver measurable cost reductions and efficiency improvements.According to Dorman, "The success of Drake Business Services Asia in Japan and across the region, coupled with growing acceptance of Kryterion's highly secure digital test development and test delivery services - especially in Japan's high technology sector - have prompted our decision to expand Kryterion's current presence in Japan dramatically."Contact Information:Yoshinori Nambo, Japan Sales Manager, Kryterion, Inc.Email: ynambo@KryterionOnline.com Website: www.Kryterion.com  Buzz Walker, Chief Revenue Officer,  Kryterion, Inc.Email: bwalker@KryterionOnline.com Website: www.Kryterion.com  Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

KUALA LUMPUR, MALAYSIA, Oct 24, 2024 - (ACN Newswire via SeaPRwire.com) - JBL®, the renowned lifestyle audio brand under Harman International, celebrated the launch of the “JBL Rewind Revolution Roadshow” today, bringing the party to life with its portable JBL PartyBox speakers and JBL PartyLight. Using AuracastTM technology, JBL PartyBox and JBL PartyLight sync seamlessly with each other and the music, creating a next-level sensory experience.JBL PartyLight BeamJBL PartyLight StickFor a more personal experience, the flagship True Wireless Stereo (TWS) earbuds, JBL Tour Pro 3, which is the first TWS with Auracast by JBL, rocketed onto the roadshow, with a Smart Charging Case with feature rich touchscreen, Real-Time True Adaptive Noise Cancelling and new audio transmitter for in-flight. The JBL Rewind Revolution Roadshow runs from 21-27 October at Mid Valley Mega Mall, East Entrance Atrium.The latest products designed to elevate your get-together or events are the JBL PartyLight Beam and JBL PartyLight Stick. While both add dynamic lighting synced to the best of the music, the JBL PartyLight Beam is a compact unit ideal for kinetic lighting effect. The JBL PartyLight Stick stands around one meter tall, is great for adding 330º room-filling mood enhancing features to your playlist. Both products use AuracastTM technology to connect effortlessly to a JBL PartyBox with a simple push of a button on each device. Control the speed, colours and patterns from the JBL PartyBox app. The built-in microphone with music detection algorithm, allows JBL PartyLight Beam and JBL PartyLight Stick to sync to the music playing in the room.The roadshow also featured JBL Partybox Club 120 and JBL PartyBox Stage 320, showcasing impressive JBL Pro Sound, sub-grille lights, and battery-powered performance. Whether it is dance or R&B, JBL PartyBox speakers deliver JBL’s renowned high-quality sound. These portable speakers come with a plethora of controls and features from the product-topping control panel, built-in handle, replaceable battery, IPX4 splashproof resistance, microphone and guitar inputs, plus Bluetooth to connect to your favourite music app from your preferred device.Mr. Henry Yap, Managing Director of Global Best United (M) Sdn Bhd said, “You can now party outside the box and enter a whole new soundscape with JBL PartyLight Beam and JBL PartyLight Stick as your essential elements for creating unforgettable parties. Whether it’s a holiday party or an intimate evening, synchronised music and lights can set the perfect mood.”“While JBL PartyBox Club 120 and JBL PartyBox Stage 320 can be paired with JBL PartyLight Stick and JBL PartyLight Beam, it is also very versatile and sturdy for use outdoor and indoor. Both comes with powerful JBL Pro Sound, futuristic lightshow, and splash proof, you can use it as a speaker or add a microphone, you can take your karaoke parties and outdoor celebrations to the next level”, Henry added.Mr. Mitchell Wong, Business Development Manager for JBL Malaysia said, “The technological advancements of the JBL Tour Pro 3 offer a feature-rich, fully customisable system. The JBL Tour Pro 3 is the flagship TWS earbud from JBL, with the latest audio technology like JBL Spatial 360 with Head Tracking, True Adaptive Noise Cancellation 2.0 and the first dual driver earbud.”The dual-driver design in the JBL Tour Pro 3 enhances audio performance, reducing distortion and improving sound clarity. The True Adaptive Noise Cancellation 2.0 system monitors and recalibrates over 50,000 times per second, recalibrating to adapt to environmental changes and compensating for sound leakage. The earbuds also ship with five additional ear-tips options - four silicon and one foam - for enhanced comfort and fit. Available in two colours, black and latte, the JBL Tour Pro 3’s smart case screen can be personalised with a photo, wallpaper and supports 13 languages.Availability. All featured JBL® products are available for purchase at Lazada, Shopee, and all leading retailers:ALL IT, Viewnet, Urban Republic, Thundermatch, Vivid Concepts, PC Image, SY Electric, THT, One Living, Harvey Norman, AES, Central Electronics, SS Audio, Brightstar Computers, Style Laser and EKS.Find out more about the JBL Products at https://www.jblonlinestore.com.my.Hi-Res Images. Please download hi-res product and lifestyle images from this link.For media information, kindly contact:Triven Marketing Group, for JBL® MalaysiaJazzmin WanEmail: j.wan@swanconsultancy.biz Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

Washington, D.C., Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Online scams wreak havoc across the Americas and globally, causing significant financial and emotional damage. The Global Anti-Scam Summit (GASS) Americas 2024, organized by the Global Anti-Scam Alliance (GASA) and hosted by Amazon.com, Inc., aims to combat these growing threats. The summit will feature over 30 hours of presentations, workshops, and interactive sessions across ten critical tracks, all focused on developing a global defense strategy to protect consumers and inform regulation.The summit will empower experts to take decisive action by focusing on the impact on victims, highlighting global scam statistics, explaining emerging scam tactics, and fostering international cooperation. The aim is to provide a roadmap for regulatory bodies to drive meaningful change.With $1.026 billion in global scam losses in 2023, this event seeks to mitigate further damage in 2024 and beyond.Day 1 will address the human and policy aspects of scams:Victim Impact: Led by AARP, this session delves into the emotional and financial toll on victims and their communities.Policy: The Aspen Institute will explore regulatory gaps and legislative solutions, sharing best practices from around the world.Law Enforcement: Chaired by UNODC, this session focuses on the collaboration between local and international agencies to disrupt scam networks.Data & Signal Sharing: GASA and DNS Research Federation will unveil plans for an international cybercrime exchange to reduce cybercrime by 50% in 10 years.Bank Collaboration: This session, led by Feedzai, will explore the critical role of banks in preventing scams.Day 2 will shift to specific industries and technologies most at risk:Financial Services: Featuring industry leaders like Capital One and Mastercard, this session will explore how multi-sector collaboration can build the perfect anti-fraud infrastructure.Telecom: Focuses on how telecom companies can improve security to protect consumers.Customer Digital Experience: Major platforms like Amazon will discuss how to strengthen protections at key digital touchpoints.Blockchain: Investigating scams in crypto and blockchain, chaired by Cube3.AI.Cybersecurity: Trend Micro will lead panels on advanced investigation techniques, focusing on scams like sextortion and pig butchering.Uniting Expertise for a Scam-Free Future"Consumers globally are facing a crisis with scams. Governments, private industry, and law enforcement must come together and act now," says Jorij Abraham, Managing Director of GASA. "Our aim at this summit is not only to discuss the problems but to build solutions that protect consumers worldwide."Confirmed Speakers:Glen Prichard, UNODCJean-Jacques Sahel, GoogleMatthew Noyes, U.S. Secret ServiceLaura Quevedo, MastercardBen Chance, ZelleAmy Nofziger, AARPMauro Ellovitch, MPMGThe summit will also launch the annual Global State of Scams Report 2024, offering an in-depth analysis of major scam trends and their impact.Join us in Washington, D.C., for this landmark event. Visit gasa.org/gass-2024-americas to view the full schedule and register.Contact InformationSam RogersMarketing Director, Global Anti-Scam Alliancesam.rogers@gasa.orgSOURCE: Global Anti-Scam Alliance (GASA) Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

SINGAPORE, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Vyasa Yoga SG, Singapore’s leading yoga institute, proudly celebrated its Silver Jubilee this month, marking 25 years of transforming lives through yoga and holistic health practices. Founded with S-VYASA, Vyasa Yoga SG has empowered thousands through its scientific, research-based yoga training and therapy programs, building a community of 3,000 certified yoga instructors and 500 yogi health therapists.The Silver Jubilee celebrations were inaugurated by esteemed guests, including Deputy High Commissioner of India Pooja Tillu, Neil Parekh, Chairman of Singapore Indian Chamber of Commerce and Industry (SICCI), Dr. H R Nagendra Guruji, Padma Shri awardee and renowned yoga guru, and Dr. Manjunath NK, Vice-President of the Asian Yoga Therapy Association, alongside Vyasa Yoga SG Founder, Manoj Thakur.To commemorate the milestone, Vyasa Yoga SG hosted the **International Conference on "Comprehensive Wellness Strategy" from October 19th to 20th, 2024 at the Galaxy Ballroom, CSC Tessensohn Club. The conference brought together 50 experts from 11 countries to explore integrating ancient yoga wisdom with modern science to enhance well-being. In her keynote address, Deputy High Commissioner Pooja Tillu emphasized the global relevance of yoga, stating: “Continue embracing yoga practice as a guiding light that will bring us together as a global family.”Manoj Thakur, Founder of Vyasa Yoga SG, reflected on the institute’s journey, “It has been a remarkable 25-year journey. Our success reflects the spirit of well-being we have cultivated in Singapore and beyond. We look forward to guiding people towards healthier, happier lives for many more years to come.”The event featured live yoga demonstrations and a special recognition ceremony to honor the institute’s significant contributions to health and wellness in Singapore. Vyasa Yoga SG is planning a series of events throughout the year to celebrate its 25th anniversary.About Vyasa Yoga SGEstablished to promote a healthy lifestyle through a scientific approach to yoga, Vyasa Yoga SG offers a variety of accredited programs for all ages and levels. With a mission to foster a culture of well-being, the institute continues to be at the forefront of holistic health in Singapore. For more information, visit  https://vyasasingapore.com/. For further media queries contact:Ganesh Somwanshiganesh@mettai.world Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

SHANGHAI, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, through the "Hong Kong and Macau Medicine and Equipment Connect" policy, VELSIPITY(R) has officially been approved for patients with moderately to severely active ulcerative colitis (UC) by the Guangdong Provincial Medical Products Administration and can first be used in the Foshan Fosun Chancheng Hospital and the First Affiliated Hospital of Sun Yat-sen University, two of the medical institutions designated by the "Hong Kong and Macau Medicine and Equipment Connect" policy in the Greater Bay Area. Subsequently, VELSIPITY(R) will be introduced in other qualified hospitals under the connect policy. VELSIPITY(R) is now the third commercialized product of Everest Medicines.VELSIPITY(R) is an innovative advanced therapy that was officially approved by the Pharmaceutical Administration Bureau of Macau in April 2024. It is an oral treatment taken once daily for the treatment of patients aged 16 and above with moderately to severely active UC. UC is a chronic, relapsing, non-specific inflammatory disease, and as the disease progresses, the risk of disability and colorectal cancer incidence continues to rise. By 2030, the number of patients with UC in China is expected to more than double compared to 2019, reaching approximately 1 million, with a significant unmet need for innovative therapies.“The launch of VELSIPITY(R) in the Greater Bay Area accelerates the access to this advanced therapy in mainland China, offering a new option for patients with moderately to severely active UC." Said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “Everest Medicines is committed to expeditiously delivering innovative therapies to patients. Moving forward, we will keep leveraging our strengths and exploring innovative ways to improve the accessibility of these therapies. We plan to have VELSIPITY(R) submitted for new drug application in mainland China by the end of this year, further enhancing its accessibility and benefiting more patients." VELSIPITY(R) was developed by Arena Pharmaceuticals, which was acquired by Pfizer in 2022. Everest Medicines obtained exclusive rights to develop, produce, and commercialize VELSIPITY(R) in Greater China and South Korea from Arena as early as 2017. As a core product in the field of autoimmune diseases for Everest Medicines, VELSIPITY(R) was successively approved in Macau and Singapore in the first half of this year and was approved in the United States and the European Union in October last year and February this year, respectively. In addition, Everest Medicines recently submitted an new drug application for VELSIPITY(R) in Hong Kong, China.VELSIPITY(R) is the first and only advanced oral UC therapy approved for use in patients 16 years of age or older in the EU, and the ELEVATE UC 52 and ELEVATE UC 12 were the only studies of advanced therapies for UC to include patients with isolated proctitis. In the results of the Asian multi-center Phase 3 clinical trial of VELSIPITY(R) for the treatment of moderately to severely active UC announced in July this year, VELSIPITY(R) achieved positive topline data results in both the induction and maintenance treatment periods, with good safety profile, and is convenient to take once a day, providing further solid scientific basis and support for the wide application of the drug in clinical practice.About VELSIPITY(R) (etrasimod)VELSIPITY(R) is a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5. Regulatory approvals have been granted in US, EU, Canada, Australia, Singapore, UK, Switzerland, Israel and Macau for VELSIPITY(R) in ulcerative colitis.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

HONG KONG, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) -  The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the “C.C. Tan Life Science Industrialization Award”. C.C. Tan Life Science Award has the highest honor as “the Chinese Nobel” in life science. In the context of the comprehensive construction of Chinese-style modernization and the development of new productivity, this award is a high recognition of Dr. Chen Li's outstanding contributions to the industrialization of life science achievements, and a full affirmation of his decades-long efforts to promote conceptual, technological and institutional innovations in biopharmaceutical industry.Dr. Chen Li participated in the award ceremony and received the “C.C. TanLife Science Industrialization Award”.“C.C. Tan Life Science Award” was proposed by Mr. Tan Jiazhen, one of the founders of modern genetics in China and an outstanding scientist and educator in modern China, which was approved by the Ministry of Science and Technology of the People's Republic of China, aims to promote the industrialization of China's life sciences research results and stimulate life scientists to make innovations. Since its establishment in 2008, C.C. Tan Life Science Award has been awarded annually to scientists, professors and young scholars who have made achievements in life science in the People's Republic of China and have made outstanding contributions to the industrialization of scientific and technological achievements in life science.With more than 30 years of experience in new drug R&D and management, Dr. Chen Li returned to Shanghai from the U.S. in 2004, and participated in the establishment of Roche R&D Center, the first R&D center of a multinational company in Shanghai, bringing the advanced experience, talent concept, technical standards and quality management system of international new drug R&D to China, and contributing to the establishment of the environment of China's biopharmaceutical industry. Dr. Chen Li has contributed to the establishment of China's biopharmaceutical industry environment.In 2010, Dr. Chen Li founded Hua Medicine in Zhangjiang, Shanghai, with the original intention of “China leads the way in pharmaceutical innovation”, adhering to the tenet of “patients first, innovation first, and good medicines for the people”, focusing on the unmet clinical needs, and concentrating on the research and development of first-of-its-kind new medicines for diabetes. Dr. Chen Li is not only one of the earliest pioneers to leave his executive position at a multinational pharmaceutical company to start a local innovative drug company, but also a leader in developing First-in-Class drugs in China.In September 2022, under the leadership of Dr. Chen Li, Hua Medicine's world's first, China's first, Class I National New Drug, Dorzagliatin (trade name: HuaTangNing®), which took ten years to develop independently, received marketing approval from the State Food and Drug Administration (SFDA), making it the first Glucose Kinesin Activator (GKA) approved and marketed globally, and the tenth class of diabetes therapeutic drugs.As the world's first GKA drug, Dorzagliatin utilizes the new concept of “repairing sensing, reshaping homeostasis, and treating diabetes at the source” to achieve the improvement of blood glucose homeostasis dysregulation in patients with type 2 diabetes mellitus, and to bring a brand-new treatment for diabetes mellitus patients, which is a major breakthrough in the history of drug research and development of China in the field of major chronic diseases.  During the development of Hua Medicine, Dr. Chen Li has actively contributed to the development of China's biopharmaceutical industry. He has provided constructive opinions and suggestions for the system of marketing license holders and the system of patent linkage and patent protection, etc. He has cooperated with enterprises in the industry chain in the R&D and production of dorzagliatin to establish a joint innovation model, which has led to the development of the ecological development of the biopharmaceutical industry. In early 2024, Dr. Chen Li was awarded the first “Shanghai Outstanding Talent”. He is also the inventor of 119 granted invention patents and 270 invention patent applications and has been published more than 70 scientific papers in Nature Medicine, Lancet Diabetes Endocrinology, Nature Communication, PNAS, Diabetes, Obesity Metabolism, and the Journal of Biomedicine. PNAS, Diabetes, Obesity Metabolism, JACS, JOC and other international academic journals.About Hua MedicineHua Medicine is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin on hydrochloride-tolerated T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with varying degrees of renal function impairment (including end-stage renal impairment without dialysis). Hua Medicine partnered with Bayer, a leading global pharmaceutical company, to commercialize HuaTangNing in China, benefiting diabetic patients and their families.For more informationHua MedicineWebsite:  www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

DUBAI, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Dubai International Financial Centre (DIFC), the leading global financial hub in the Middle East, Africa and South Asia (MEASA) region, announces the 2nd edition of the Future Sustainability Forum. Scheduled for 4 and 5 December 2024 at the Madinat Jumeirah, Dubai, the Forum will focus on mobilising sustainable practices, engaging in influential discussions on sustainable development, working towards environmental conservation, social equity and innovation.The announcement of the 2nd edition of the Forum underscores DIFC’s commitment to advancing UAE sustainability priorities alongside initiatives such as the DIFC Sustainable Finance Catalyst which aims to grow sustainable finance flows from Dubai to USD 100+ billion by 2030.The Forum coincides with the first anniversary of COP28 being hosted in the UAE and is set to attract over 3,000 participants. The event will mobilise industry leaders, investors, tech disruptors, and policymakers into achieving the United Nations Sustainable Development Goals (SDGs) and contributing to the delivery of the Paris Agreement, whilst aiming to channel investment flows between the global north and south to accelerate climate action.Alya Al Zarouni, Chief Operating Officer of DIFC Authority and Co-Chair of the Dubai Sustainable Finance Working Group, said, “The DIFC organised Future Sustainability Forum is a vital platform for collaborative action towards a more sustainable future. As the global economic landscape evolves, so must our commitment to responsible and inclusive growth. At DIFC, we are proud to be convening this gathering of industry leaders, innovators, and policymakers to address the most pressing environmental and social challenges of our time. Together, we can forge new pathways to a more resilient and sustainable future for financial services and other important industries.”Dr Bernd van Linder, Chief Executive Officer of the Commercial Bank of Dubai, the presenting sponsor of the Forum, stated, "Commercial Bank of Dubai is proud to support the UAE's sustainability ambitions through our participation in the Future Sustainability Forum 2024 as Presenting Sponsor. Our proactive approach in addressing environmental challenges, exemplified by the successful issuance of CBD's inaugural green bond, demonstrates our alignment with global environmental goals."The Forum will address critical sustainability issues across eight core pillars spanning different industries including banking and finance, construction, renewable and future energy, transportation and mobility, manufacturing and production, recycling and waste management, sustainable technology, and agriculture and food production.In addition to the packed conference agenda that will feature over 100 sustainability and climate action expert speakers, the Forum will bring together the most innovative solutions and service providers from across the global sustainability landscape through the Climate Action & Renewable Energy Expo (CARE).Government entities in the UAE have spearheaded a range of comprehensive sustainability programmes in the pursuit of a net-zero future. Initiatives such as the Dubai Clean Energy Strategy 2050, the UAE Net Zero 2050 strategic initiative, and the UAE Vision 2070, emphasise on a commitment to renewable energy adoption, water conservation, waste management, and sustainable urban development.For more information and to register, please visit the Future Sustainability Forum website.About Dubai International Financial CentreDubai International Financial Centre (DIFC) is one of the world’s most advanced financial centres, and the leading financial hub for the Middle East, Africa, and South Asia (MEASA), which comprises 77 countries with an approximate population of 3.7bn and an estimated GDP of USD 10.5trn.With a 20-year track record of facilitating trade and investment flows across the MEASA region, the Centre connects these fast-growing markets with the economies of Asia, Europe, and the Americas through Dubai. DIFC is home to an internationally recognised, independent regulator and a proven judicial system with an English common law framework, as well as the region’s largest financial ecosystem of 43,800 professionals working across over 6,150 active registered companies – making up the largest and most diverse pool of industry talent in the region. The Centre’s vision is to drive the future of finance through cutting-edge technology, innovation, and partnerships. Today, it is the global future of finance and innovation hub offering one of the region’s most comprehensive FinTech and venture capital environments, including cost-effective licensing solutions, fit-for-purpose regulation, innovative accelerator programmes, and funding for growth-stage start-ups.  Comprising a variety of world-renowned retail and dining venues, a dynamic art and culture scene, residential apartments, hotels, and public spaces, DIFC continues to be one of Dubai’s most sought-after business and lifestyle destinations. For further information, please visit our website: difc.ae, or follow us on LinkedIn and X @DIFC.For media enquiries, please contact:Nivine William | Nisha CelinaBurson | bursonglobal.comnivine.william@bursonglobal.com | nisha.celina@bursonglobal.com Rasha Mezher | Dubai International Financial Centre Authority Manager, Marketing & Corporate CommunicationsRasha.Mezher@difc.ae Hussain AlZaabi | Dubai International Financial Centre AuthorityManager, DIFC Innovation Hubhussain.alzaabi@difc.ae Shadi DawiDirector - PR & Media+971 55 498 4989shadi@tresconglobal.com  Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 25 10 月, 2024

HONG KONG, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, will present at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting®, taking place from November 15-19, 2024 in San Diego, California. The presentations include post-hoc analyses of the Phase 2a clinical study of berberine ursodeoxycholate (HTD1801), a gut-liver anti-inflammatory metabolic modulator, in patients with metabolic dysfunction-associated steatohepatitis (MASH) and comorbid type 2 diabetes mellitus (T2DM) (NCT03656744).“These data provide additional characterization of the efficacy and safety of HTD1801, a novel, multifunctional therapy being developed for the treatment of patients with MASH and T2DM. If further studies confirm these findings, HTD1801 could potentially offer a more effective solution for patients who do not respond adequately to GLP-1 receptor agonists.  In addition, the observations of improved GI tolerance over time suggests that HTD1801 may be an attractive option for long-term management of chronic conditions such as MASH and T2DM. The ongoing Phase 2b study (CENTRICITY, NCT05623189), fully enrolled in 1Q 2024, evaluates the histological benefit of HTD1801 in patients with MASH and T2DM. We look forward to announcing the CENTRICITY results which we expect in the first half of 2025,” said Dr. Leigh MacConell, Chief Development Officer of HighTide.“Efficacy of Berberine Ursodeoxycholate (HTD1801) Compared to Ongoing Use of GLP-1 Receptor Agonists in Patients with MASH and T2DM” (Abstract 3218, Poster Presented November 17th)About the Abstract: As GLP-1 Receptor Agonists (GLP-1RAs) are prominently used in patients with T2DM and gaining attention as a potential treatment for MASH, this post-hoc comparative efficacy analysis evaluated ongoing GLP-1RA use compared to newly initiated HTD1801 treatment. This analysis suggests that HTD1801 provides greater improvements in markers of liver injury and inflammation, glycemic control, weight loss, and lipid metabolism compared to ongoing GLP-1RA use. These findings are important as they suggest that HTD1801 could provide additional benefit to patients with MASH and T2DM, on concomitant GLP-1RA treatment.“Time Course of Onset, Incidence, and Prevalence of Gastrointestinal Adverse Events with HTD1801 (Berberine Ursodeoxycholate) in Patients with MASH and T2DM” (Abstract 3219, Poster Presented November 17th)About the Abstract: Across several indications, the most commonly occurring adverse events (AEs) in studies of HTD1801 have been mild to moderate gastrointestinal (GI) AEs, primarily diarrhea and nausea. The purpose of this post-hoc analysis was to characterize the time course and severity of GI AEs in patients with MASH and T2DM treated with HTD1801 for 18 weeks. Based on this analysis, the incidence of GI-related AEs peaks within the first 4 weeks of treatment, was mild to moderate in severity, and importantly, showed a decreasing incidence and prevalence over the course of treatment. These data demonstrate that HTD1801 is generally well-tolerated and with continued treatment, GI tolerance improves supporting its potential long-term use in chronic diseases, such as MASH.About HighTide TherapeuticsHighTide Therapeutics, Inc. (2511.HK) is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional multi-targeted therapies with chronic liver and metabolic diseases with significant unmet medical needs. The company is developing multiple clinical assets, including therapy for metabolic dysfunction-associated steatohepatitis (MASH), type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), and primary sclerosing cholangitis (PSC). Berberine ursodeoxycholate (HTD1801), the company’s lead drug candidate, received Fast Track designation from the U.S. FDA for both MASH and PSC, as well as Orphan Drug designation for PSC. In China, HTD1801 has been included in the National Major New Drug Innovation Program under the 13th Five-Year Plan for Major Technology Project.For more information, please visit www.hightidetx.com Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

ROMEOVILLE, IL, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, announced today that it has been named a Platinum Partner in H.B. Fuller's Channel Partnership Program. This partnership positions the company to lead distribution efforts for H.B. Fuller's Cilbond® adhesives across North America and builds on over a decade of distribution success at Suministro de Especialidades ("Suministro"), a leading Mexican distributor acquired by Formerra in late 2023.Cilbond serves a variety of industries, including automotive applications that require rubber-to-metal bonds, such as suspension bushings, engine mounts, and anti-vibration systems.Suministro has played a pivotal role in advancing applications for Cilbond throughout Mexico. Formerra will complement this established relationship to deliver H.B. Fuller's innovative Cilbond bonding agents to the broader North American market, offering a unique combination of technical expertise, sustainable solutions, and customer support. Combined with Formerra's expansive reach, this will enable support for manufacturers in streamlining their processes and improving production.The Cilbond product line offers specialized bonding agents that cater to Power Grid, Transportation, Industrial, Oil, Gas & Mining industries, and more.Cilbond provides a variety of coating systems, ranging from the conventional two-coat system, known for its durability and bonding strength, to a cutting-edge one-coat system. Cilbond's one-coat options deliver a streamlined solution, saving both time and cost for customers. With additional water-based options, Cilbond aligns with the growing demand for more sustainable products, enabling manufacturers to reduce their potential environmental impact without sacrificing performance."Our new relationship with Formerra marks a significant step forward in our North American growth strategy," said Tim O'Neil, Managing Director at H.B. Fuller. "By combining Formerra's strong portfolio of complementary materials and technical expertise with our innovative technology, we're able to provide advanced solutions that meet the evolving needs of manufacturing customers. Together, we're well-positioned to help them increase efficiency, reduce costs, and meet sustainability goals.""We're confident that our deep technical capabilities, combined with Suministro's proven track record, position us to maximize the potential of this partnership for both parties," said Doug Zupan, Vice President of Operations at Formerra. "In bringing H.B. Fuller's innovative bonding solutions to the rest of North America, we intend to deliver exceptional value and support to our customers."About HB FullerAs the largest pureplay adhesives company in the world, H.B. Fuller's (NYSE:FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2023 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,000 global team members who collaborate with customers across more than 30 market segments in over 140 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.Contact InformationJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - October 23, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to provide a technical update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.PRODUCT TECHNICAL UPDATETHERMAL-XR® has now successfully passed 15,000 hours for corrosion protection under a salt sea spray industry standard test (ASTM B117) in a third-party laboratory in the US as seen in Figure 1. The Company believes that THERMAL-XR® is one of the longest lasting corrosion protection coatings available on the market. The testing will continue, and further reports will be updated by the Company.Figure 1: THERMAL-XR® Coating Corrosion Test Results After 15,000 Salt Sea Spray Hours (ATM B117)To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_ecd3ffa9c41478c4_001full.jpgGMG can now accurately model and calculate the heat transfer rate expected from THERMAL-XR®, as compared to bare (uncoated) Aluminium, within 1% of actual results. This was reviewed and verified by the University of Queensland.Figure 2 shows the simulation model used to calculate the heat transfer coefficients of bare aluminium, versus THERMAL-XR® coated aluminium, on the test rig that GMG built and operated to obtain the experimental data. The test was conducted at a temperature of approximately 100 degree Celsius.Figure 2: Estimation of Heat Transfer of THERMAL-XR® coated aluminium versus bare aluminiumTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_gmg_figure2.jpgThrough this work, as shown in Figure 3, the Company has demonstrated that THERMAL-XR® provides approximately 8.6 times more radiative heat transfer than bare aluminium, due to its thermal radiation (passing of heat in wave forms) capabilities. THERMAL-XR® has been calculated to provide 8.15 W/m2K (Watts per metre squared Kelvin degrees), or approximately 1.44 Btu/hr ft2 F (British thermal units per hour foot squared Fahrenheit degrees), of heat transfer when applied properly on top of bare aluminium, as compared to 0.95 W/m2K or 0.17 Btu/hr ft2 for bare aluminium.Figure 3: Thermal Radiation calculations of THERMAL-XR® coated aluminium versus bare aluminiumTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_ecd3ffa9c41478c4_004full.jpgFigure 4 shows THERMAL-XR® increases the overall heat transfer coefficient by 2.2 times more than bare aluminium, from 6.0 W/m2K up to 13.2 W/m2K because of the increase in the thermal radiation from the THERMAL-XR® coating. This was conducted at a temperature of approximately 100 degree Celsius for a 100mm diameter flat plate.Thermal Coefficient (W/m2K)Bare AluminiumTHERMAL-XR® Coated AluminiumThermal Radiation0.958.15Natural Convection (Air Cooling)5.085.08Total Heat Transfer6.013.2(2.2 Times)Figure 4: NATURAL Convection Overall Thermal Coefficient of THERMAL-XR® versus bare aluminiumFigure 5 shows that THERMAL-XR® provides approximately 27% more heat transfer when including FORCED convection (fan air cooling) over bare aluminium from 26.6 W/m2K up to 33.8 W/m2K because of the increase in the thermal radiation from the THERMAL-XR® coating. This was conducted at a temperature of approximately 100 degree Celsius and with modelling of the air speed at an approximate 5 metres/second.Thermal Coefficient (W/m2K)Bare AluminiumTHERMAL-XR® Coated AluminiumThermal Radiation0.958.15Forced Convection (Fan Air Cooling)25.7125.71Total Heat Transfer26.633.8(27% Increase)Figure 5: FORCED Convection Cooling Overall Thermal Coefficient of THERMAL-XR® versus bare aluminiumGMG's Managing Director and CEO, Craig Nicol, commented: "GMG continues to make good progress in testing THERMAL-XR® for corrosion protection and heat transfer - our increased understanding of the heat rejection rate of the product allows us to better recognise how it can be of potential value for various types of products in various applications and markets."GMG's Chairman and Director, Jack Perkowski, commented: "THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into so many industries - so it is great to see the progress."About THERMAL-XR® powered by GMG Graphene:THERMAL-XR® COATING SYSTEM is a unique method of improving the heat conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces increasing service life, while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR RESTORE® is powered by GMG Graphene. PATENT PENDINGAbout GMG www.graphenemg.comGMG is a clean-technology company which seeks to offer energy saving and energy storage solutions, enabled by graphene, including that manufactured in-house via a proprietary production process. GMG has developed a proprietary production process to decompose natural gas (i.e. methane) into its elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating), lubricants and fluids.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries").GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, that the Company will continue testing THERMAL-XR® and provide further updates, that increased understanding of THERMAL-XR® will allow the Company to better recognize how it can add value in various types of products in various applications and markets, and that THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into many industries. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will continue to test THERMAL-XR® and provide updates, that an increased understanding of THERMAL-XR® will enable the Company to better identify how THERMAL-XR® can add value for various products in various applications and markets, and that THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into many industries. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the Company will not continue testing THERMAL-XR®, that the Company will not provide further updates regarding THERMAL-XR®, that a better understanding of THERMAL-XR® will not allow the Company to better recognize how it can add value in various types of products in various applications and markets, that THERMAL-XR® testing in corrosion protection and heat transfer will not be highly translatable into many industries, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227525 Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

HONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - HK equity market experienced snap adjustment rally in September, and is now entering stock picking phase before new round of catalyst arrives. Now is the period when investors explore resilient names whose fundamentals is robust enough to weather market turbulence. Fosun International (00656) fits into this category, with its continuous efforts on innovation and globalization, combined with solid delivery on financial result and attractive valuation.Fosun International is one of the few leading enterprises rooted in China with global operational capabilities. Since its establishment in 1992, Fosun International has built an industrial presence in more than 35 countries and regions worldwide, continually enhancing its global operational capabilities. It has now become a global innovation-driven consumer group.Enhancing innovation capabilities while delivering robust global operational capabilitiesOver past decades, Fosun has been enhancing and deepening its globalization capabilities via launching new products and advancing its international operation.Take pharmaceutical products for example, the biosimilar HANQUYOU has pioneered the international market expansion for Fosun. With licensing agreements covering approximately 100 countries and regions and marketing approvals in 48 countries and regions, HANQUYOU has become the China-developed biosimilar with the most marketing approvals.Thanks to the overseas expansion of biosimilars, Fosun has not only established its reputation internationally, but has also gained experience in the globalization of first-in-class drugs. HANZISHUANG, the world's first anti-PD-1 monoclonal antibody approved for the first-line treatment of small cell lung cancer (SCLC) independently developed by Shanghai Henlius, is an example of success. Fosun's overseas expansion of biopharmaceutical has resulted in the advancement of both first-in-class drugs and biosimilars. In 2023, Shanghai Henlius became the first first-in-class pharmaceutical company among its peers to achieve profitability through product sales.In terms of operations, Fosun International focuses on organization evolution and global resource integration. By leveraging regional advantages, it establishes a profound industrial presence and localized operations to continuously benefit its industries and brands.For example, in the tourism sector, Fosun Tourism Group (FTG) has achieved remarkable growth through its unique asset-light operating model, global presence and global operations. FTG's subsidiary Club Med, which operates 67 resorts worldwide, achieved a record-high business volume of RMB8.89 billion in the first half of 2024, representing a year-on-year increase of 10.3%. Its business in the Europe, Middle East and Africa (EMEA) region and the Americas continued to grow, while its business in Asia-Pacific region recovered significantly. In May 2024, Club Med signed an agreement in Oman for the launch of its first resort in the Middle East.Notably, there are very few domestic tourism companies that adopt an asset-light operating model and are equipped with global operational capabilities, making FTG a benchmark for the development of China's tourism industry. In addition, Fosun International continues to drive innovation and optimization in the consumption and insurance sectors, making positive impact on China's economic growth and industrial upgrades.As Fosun International enhances its focus on its "products + operations", its globalization capabilities are gradually bearing fruit, while its innovation capabilities are further developing. This approach has effectively strengthened its advantages in core industries such as tourism, consumption, pharmaceuticals, and insurance, garnering market optimism.S&P affirms Fosun International's "stable" rating outlook, noting that creditworthiness remains steadyRecently, Fosun International received further recognition in the international rating agencies. On 21 October, S&P released a report acknowledging Fosun's successful asset divestment and debt reduction efforts, assigning it a stable rating outlook.Specifically, S&P acknowledges the improvement of Fosun's liability structure, noting that bank loans now account for 73% of the holding company's debts, up from 46% in mid-2022. Fosun International completed a USD888 million offshore syndicate in September 2024, reflecting an increase in both bank participation and size compared to the syndicate due in May. S&P regards this as a clear evidence of recovery in offshore bank refinancing channels.The smooth access to financing channels reflects the confidence of domestic and international financial institutions in Fosun's financial position and business strategy. This not only reduces Fosun's reliance on public market financing but also allows for better support of liquidity management and greater flexibility to manage the pace of future asset divestment. S&P expects Fosun's asset recycling could continue to drive further debt reduction.The positive evaluation from S&P affirms Fosun International's strong execution of its globalization and innovation capabilities. Over the past two years, the remarkable improvement in its balance sheet and enhanced financial resilience have been evident. Additionally, this endorsement reinforces the company's investment value.Overall, as the outlook for the Chinese economy improves, especially with the implementation of key policy initiatives, the Hong Kong stock market holds significant growth potential. Thanks to its global presence, integrated innovation, and asset-light operating strategy, Fosun International is enhancing performance certainty and strengthening its financial resilience against risks. As its global operations continue to expand, industry-leading advantages strengthen, and the benefits of technology innovation accelerate, Fosun is poised to capitalize on the next wave of growth in the Hong Kong stock market. Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

- HKSAR Under Secretary for Financial Services and the Treasury Joseph Chan honoured the event by delivering opening remarks- Returning after six years, the Asian Actuarial Conference 2024 receives overwhelming support from over 1,000 international professionals- Expertise of actuaries can reinforce Hong Kong’s capability as a premier risk management centre, therefore contribute to the resilience and sustainable growth of the cityHONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - The three-day Asian Actuarial Conference 2024 (AAC 2024) organised by the Actuarial Society of Hong Kong (ASHK), commenced today at the Ocean Park Marriott Hotel. This year's conference, themed “Exploring the Future of Insurance and Beyond: Innovation, International Hubs, and Hong Kong,” has more than 100 internationally renowned experts from diverse industries as speakers and panellists, and close to 1,000 participants including actuarial professionals, executives, and thought leaders from across Asia and beyond, making it a significant gathering in the actuarial community.Mr. Joseph Chan, Under Secretary for Financial Services and the Treasury of the HKSAR, officiated the opening ceremony together with Mr. Timothy Wong, President of the Actuarial Society of Hong Kong, Mr. Stephen Yiu, Chairman of the Insurance Authority, and Ms. Daisy Ning, Head Life & Health APAC ex China of Swiss Re.Timothy Wong, President of the ASHK, said, “We are delighted to have top business leaders in the region coming to Hong Kong to join AAC 2024, returning to the city after six years. Apart from allowing us, actuaries and insurers, to gain valuable insights on the evolving landscape of the professions, the Conference is also a vital platform for us to connect with practitioners in other professions that have wide-reaching implications for the future of ours. With the market changing so rapidly, it is essential for actuaries to stay abreast of latest industry developments and to unlock the vast potential of actuarial science to the benefit of diverse fields. Together, we are paving the way for growth of the actuary profession in Hong Kong.”Alongside technologies advancing at ever faster speed and with business opportunities of all kinds emerging in the Greater Bay Area, financial markets in the region have also become more complex and sophisticated. More companies are recognising the importance of financial planning and the need to effectively manage risks. Actuaries, equipped with a unique blend of analytical and business skills, are adept at helping businesses address diverse financial and social challenges. By developing models to assess the current financial implications of uncertain future events, they enable companies to make scientific and rational decisions.Also, taking into account the risk-based capital (RBC) regime for the Hong Kong insurance industry introduced on July 1 this year, plus the 2024 Policy Address just delivered by the Chief Executive of the HKSAR outlining ways to enhance development of the insurance sector, attract large enterprises to establish captive insurers in Hong Kong, and strengthen Hong Kong's position as a global risk management centre, actuaries are going to be in great demand in the near future.The government intends to examine capital requirements of and drive infrastructure investment, and enrich insurance companies' asset allocation for risk diversification, which are expertise areas of the actuarial profession, showing that actuaries have a  pivotal role to play in ensuring  the resilience and sustainable growth of the city.Simon Lam, Co-Chairperson Organising Committee Asian Actuarial Conference 2024  concluded, “As of December 2023, ASHK has a total of 1,293 members. With polices and regulations in its favour,  ASHK, as the leading professional body for actuaries in Hong Kong, is ready to nurture more talent for the profession to meet the rising demand.”Day Two and Three of the AAC 2024 will explore important themes such as growth in emerging Asia, Hong Kong as an international hub, regulation, artificial intelligence, blockchain, ESG, professionalism, and more. The conference will conclude on Friday with excursions for delegates to visit the Greater Bay Area, Hong Kong Cyberport, Hong Kong Science Park, and the Palace Museum.For more information please visit: https://aac2024.hk/index About the Actuarial Society of Hong KongThe professional body for actuaries in Hong Kong was first formed in 1968 as the Actuarial Association of Hong Kong, its successor, the Actuarial Society of Hong Kong (ASHK) was later incorporated in 1994. It is governed by an elected Council with a President and 14 other Council Members. Fellow Members are entitled to use the FASHK designation which is a requirement for all Insurance Authority applications for Long-Term Appointed Actuaries and General Insurance Certifying Actuaries.The ASHK sets the Professional Standards outlined in the Insurance (Actuaries’ Standards) Rules (Cap. 41, section 129(1)) and the Actuarial Guidance Notes outlined in the various Insurance Authority Guidelines for the actuarial profession in Hong Kong. www.actuaries.org.hk About the Asian Actuarial ConferenceStarting from 2013, the Asian Actuarial Conference is usually a biennial event organised by an Asian Actuarial Association member organisation on a rotational basis. It has become the most important actuarial event in Asia. To date, the Asian Actuarial Association is made up of 12 actuarial organisations with close to 25,000 members. These member organisations come from* Australia, China, Chinese Taipei, Hong Kong, India, Indonesia, Japan, Malaysia, Singapore, South Korea,  Thailand, and the Philippines.*In alphabetical order.From Left to Right:Mr. Simon Lam, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Ms. Daisy Ning, Head Life & Health APAC ex China of Swiss ReMr. Stephen Yiu, Chairman of the Insurance AuthorityMr.Timothy Wong, President of the Actuarial Society of Hong KongMr. Joseph Chan, HKSAR Under Secretary for Financial Services and the TreasuryMr. Clement Cheung, CEO of the Insurance AuthorityMr. Alex Wong, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Mr. Billy Wong, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Mr. Joseph Chan, Under Secretary for Financial Services and the Treasury of the HKSAR, honoured the event by delivering opening remarksMr. Timothy Wong, President of the Actuarial Society of Hong Kong, welcomes over 1,000 professionals from across Asia andbeyond to join this significant actuarial conference  Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

- Over 700 exhibitors from 17 countries and regions to participate from 6-8 November at the Hong Kong Convention and Exhibition Centre- Exhibition reflects four prominent market trends: technology, lifestyle, functionality and sustainability- Concurrent Hong Kong International Optometric Symposium to explore latest breakthroughs in myopia control and prevention- Finalists of the 24th Hong Kong Eyewear Design Competition to be unveiledHONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - The 32nd Hong Kong International Optical Fair, organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Optical Manufacturers Association (HKOMA), will take place on 6-8 November at the Hong Kong Convention and Exhibition Centre. Under the theme of Seeing is Believing, the Fair features innovative and state-of-the-art eyewear designs and products, bringing together industry players to facilitate new business opportunities.Sophia Chong, Acting Executive Director of the HKTDC emphasised: "This year’s Hong Kong International Optical Fair, a long-standing industry highlight for over 30 years, is more international than ever, attracting more than 700 exhibitors from 17 countries and regions. The fair reflects the dynamic evolution in eyewear design and technology. Exhibitors worldwide are aligning their products with key trends in technology, lifestyle, functionality and sustainability to capture expanded market opportunities. This exhibition, which is truly a feast for the eyes, demonstrates Hong Kong's advantages as an international trade and procurement centre."Hong Kong ranks as the world's third-largest exporter of eyewear and frames. The total export value of Hong Kong's eyewear, lenses and frames is estimated to have reached HK$19.9 billion in 2023, signalling substantial growth. The smart eyewear sector has emerged as an industry focal point, with the global market exceeding HK$40 billion in 2023 and projected to surpass HK$100 billion by 2029.Exhibitors from around the globe, including Europe and Americas, such as France, Germany, the United Kingdom and the United States, as well as Asia such as Japan, Korea, Malaysia, Singapore, Taiwan, and Türkiye in the Middle East, and more, will present their latest offerings at the fair. Prominent Hong Kong brands will also have a significant presence.This year’s Optical Fair will feature a number of group pavilions, including Mainland China, Japan, Korea and Taiwan, as well as the Visionaries of Style and HKOMA Pavilion; along with pavilions from cities in Mainland China, including Danyang in Jiangsu, Jiaojiang in Zhejiang, Shenzhen in Guangdong and Yingtan in Jiangxi.The Brand Name Gallery, the focal point of the Fair, will showcase over 200 renowned global brands. Other zones will present a broad spectrum of eyewear products, including Smart Eyewear, Contact Lenses & Accessories, Designer Café pavilion, Sporting & Professional Eyewear, Kids Eyewear & Reading Glasses, Lenses, Frames & Parts, Eyewear Accessories, Diagnostic Instruments, as well as Optometric Instruments, Equipment & Machinery.The 22nd Hong Kong International Optometric Symposium will be held on 7 November. Jointly organised by the HKTDC, the Hong Kong Optometric Association and The Hong Kong Polytechnic University, this year's symposium will focus on myopia control and prevention. Scholars from Mainland China, Hong Kong, Australia, and Germany will lead discussions with industry professionals. The symposium is a pre-approved CPD Programme recognised by the Optometrists Board and attendees will receive a Certificate of Attendance. The Fair will also offer talks and seminars on smart eyewear, functional eyewear, sustainability and other advancements in the eyewear industry.To foster Hong Kong’s creativity and innovation, the HKTDC and HKOMA will run the 24th Hong Kong Eyewear Design Competition under the theme of Be Bold. Results will be announced during the Hong Kong International Optical Fair. Winning and final entries will be on display at The Forum, Hall 1D during the fair period to showcase Hong Kong’s creativity to international buyers.Under the EXHIBITION+ hybrid model, exhibitors and buyers can meet online through the Click2Match business matching platform in addition to attending the physical fair until 15 November. Buyers can also use the Scan2Match feature of the HKTDC Marketplace App to scan the QR codes of exhibitors and view product materials, bookmark favourites, browse product information and floor plans, as well as engage with exhibitors before and after the fairs to continue their sourcing journey.Featured ProductsExhibitors at the forefront of the industry are unveiling an array of innovative eyewear products in line with technology, lifestyle, functionality and sustainability trends. Some of the highlighted products are:TechnologySolos AirGo Vision – Smart EyewearEquipped with a camera, AirGo Vision is the world's first smart eyewear with ChatGPT-4 functionality, and provides instant responses to what you see Solos Technology LimitedProduct Zone: Visionaries of Style Booth: GH-B26Reform EyewearReform features a new patented flexible frame technology that seamlessly adapts to any frame shape, size, colour or material, suitable for both prescription and sunglasses. This innovation offers endless possibilities for eyewear design, while ensuring safety and comfort.Icare (Hong Kong) Company LimitedProduct Zone: Hong Kong Optical Manufacturers Association Pavilion Booth: 1E-C08LifestyleFashion-Forward Yagioka EyewearThe local design brand Big Horn has launched the Yagioka eyewear line, featuring a modern and refined design that is perfect for fashion-forward people. This eyewear design was a finalist for the USA Accessories Council's Design Excellence Awards 2024.The Panda eyewear series draws inspiration for its colours and shapes from the beloved animal. Crafted with precision and made from high-quality biodegradable materials, it combines functionality with aesthetic appeal.Winky International LimitedProduct Zone: Brand Name GalleryBooth: GH-R03Rosie Allan – A Design for Both Parents and ChildrenEstablished in 2020, Rosie Allan transcends being just a brand; it celebrates family bonds and unforgettable moments. Specialising in 100% handcrafted acetate sunglasses, the matching parent-child collection symbolises love and togetherness.Rosie Allan Pty LtdProduct Zone: Brand Name GalleryBooth: GH-D07Luxury Jewellery-inspired Handcrafted EyewearThis Japanese brand merges high-end jewellery design with eyewear, utilising premium materials, such as 18K gold and natural diamonds. Each pair is meticulously handcrafted with a commitment to artisanal craftsmanship and is specifically designed for Asian facial features, exuding elegance.Inon Co. Ltd.Product Zone: Japan PavilionBooth:  GH-B12Functionality:Nano Vista Children's Sports EyewearCrafted exclusively for kids and young athletes, Nano Vista - a Spanish brand - offers eyewear designed for outdoor activities. It is internationally recognised for safety, meets European EN166:2001 standards and is endorsed by top sports federations.Opticon LtdProduct Zone: Brand Name GalleryBooth: GH-C06Sustainability:Sustainable Eyewear Frame SolutionThe eyewear frames are made from BioCell material. BioCell is a cellulose acetate derived from cotton or wood pulp, certified as biodegradable according to ISO 14855 standards. It contains no industry-standard plasticisers and is compatible with polycarbonate lenses.Eleung LimitedProduct Zone: Hong Kong Optical Manufacturers Association PavilionBooth: 1E-D14Eco-Friendly Nylon and PC LensesEco-friendly nylon and polycarbonate (PC) lenses are produced using sustainable materials, reducing carbon emissions during the manufacturing process. They feature high abrasion and scratch resistance and have received multiple certifications. Even in low-temperature conditions, they maintain hardness and toughness, providing excellent clarity and optical transmission performance.Mellan LimitedProduct Zone: Frames & PartsBooth: 1E-C28 Last year’s Hong Kong International Optical Fair was a great successPhoto download: https://bit.ly/3NzTZIrWebsites:The 32nd Hong Kong International Optical Fair:https://www.hktdc.com/event/hkopticalfair/enEvent Details of the Hong Kong International Optical Fair: https://www.hktdc.com/event/hkopticalfair/en/intelligence-hub    The 22nd Hong Kong International Optometric Symposium: https://www.hktdc.com/event/hkopticalfair/en/the-22nd-hong-kong-international-optometric-symposiumThe HKTDC’s Media Room: http://mediaroom.hktdc.com/enFair Details (Physical)Date:6 – 8 November (Wednesday to Friday)Time:(6 to 7 November) 9:30am – 6:30pm(8 November) 9:30am – 5:00pmVenue:Hong Kong Convention and Exhibition CentreAdmission:For trade visitors aged 18 or above only. Onsite Registration Fee: HK$100 per person (free for e-Badge registration and pre-registered buyers)Click2Match – Smart Business Matching PlatformDate:30 October – 15 NovemberMedia enquiriesPlease contact the HKTDC’s Communications and Public Affairs Department:Johnny TsuiTel: (852) 2584 4395johnny.cy.tsui@hktdc.orgSharon HaTel: (852) 2584 4575sharon.mt.ha@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

MUMBAI, INDIA, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - WAIS India series is to take place at the Hotel Sahara Star, Mumbai on 24th October 2024. The much-awaited one-day conference will gather 500+ AI enthusiasts and tech leaders from Pan India to seek further insights as to how “GenAI Surfaces to Power AI”.As India positions itself as a global leader in digital innovation, the 43rd Global Edition of World AI Show, an event by Trescon, will highlight how it helps the enterprises and businesses.Recent industry analysis indicates that the AI market in India is experiencing remarkable growth, with a projected compound annual growth rate of 25-35 percent by 2027. Currently valued between $7-10 billion, this market is expected to surge to approximately US$ 22 billion, underscoring India’s pivotal role in the global AI revolution. This rapid expansion highlights India's increasing influence and innovative capabilities in the field of Artificial Intelligence.In line with this transformative growth, the summit will address the opportunities and challenges within the AI landscape, focusing on three critical areas: AI ethics, the integration of Generative AI, and enhancing customer experiences. Attendees will engage in discussions about responsible AI practices, ensuring transparency and fairness, and how AI can drive seamless interactions that prioritize customer satisfaction.The World AI Show will also explore the impact of Generative AI on customer service, including its role in automating routine tasks and improving operational efficiency. Discussions will highlight how ethical AI deployment fosters trust and transparency, as well as the importance of ensuring data privacy and compliance with regulations.Attendees at the event will seek further insights on the recent advancements in Generative AI models and deliberate on critical issues such as driving successful AI transformation, preparing enterprises and businesses for AI integration, navigating the next decade of technological evolution, and shaping the future of AI.Our esteemed speaker line-up:- Sumnesh Joshi, Deputy Director General, Ministry of Communication, Government of India- Ashwini Tewari, Managing Director, State Bank of India- CP Gurnani, Co-founder & Executive Vice Chairman, AlonOS- Tapan Singhel, MD& CEO, Bajaj Allianz General Insurance- Naiyya Saggi, Group Co-Founder & Board Member, Good Glamm Group- Dr Ganesh Natarajan, Chairman, Honeywell Automation & 5F World- Dr Satyam Priyadarshy, Ex Technology Fellow, Halliburton, Founder and CEO ReigniteFuture- Abhivardhan, Founder & Chairperson, Indian Society of Artificial Intelligence & Law- Tejas Shah, Chief Information Officer, L’Oreal- Kapil Chandel, EVP & Head of Data Science, Motilal Oswal Financial Services- Guruprasad Rao, Chief Analytics & Insights Officer, Tata Power- Kiran Komatla, Group Chief Technology Officer, Restaurant Brands Asia- Ankit Goenka, Senior VP, Bajaj Allianz General Insurance- Rakesh Gupta, Head Customer Services & Customer Experience, Panasonic Electric Works India- Vishal Bhatia, Chief Digital Officer, Canara Bank- Sujatha S Iyer, Head of AI Security, ManageEngine- Shvetal Desai, Co-Founder, Nividous- Gaurav Singh, Chief Technology Advisor, Pinkerton- Madhu S Dutta, Head- Marketing Communication & Content, Raymond- Akshay Yadava, Director, Unique Identifiction Authority of India (UIDAI)- Anurag Khare, Head of Digital Marketing, Ion Exchange- Juhi Singh, Head- International Ecommerce & Global Digital Centre of Excellence, Marico“AI is crucial to India's economic blueprint, catalyzing innovation and growth across diverse sectors. With this integration, we are laying a strong foundation that pushes India forward as a leader in global technology and economic development. The World AI Show provides a crucial platform that propels this vision forward, showcasing how AI can drive substantial economic benefits and position India at the forefront of global technological innovation.” - Mithun Shetty, Vice Chairman, Trescon.Sharing his enthusiasm about speaking at the event, Sumnesh Joshi, Deputy Director General of the Ministry of Communication, Government of India said, “I am excited to speak at the World AI Show in Mumbai. This event provides an excellent opportunity to connect with a global audience and share valuable insights. I look forward to discussing how digital transformation is shaping governance and impacting the broader digital economy.”Moreover, the summit will recognize the Top 100 AI Leaders during the awards ceremony. This much-anticipated segment will recognize and honor the most impactful AI professionals in India, celebrating their outstanding leadership and exceptional contributions across various sectors. Don’t miss this chance to witness and be part of a celebration that acknowledges the individuals setting new benchmarks in AI.The 43rd Edition of the World AI Show is supported by:Platinum Partner – MAGURE Tech Middle EastGold Partner – Manage EngineSilver Partner – NividousExhibitors – ADQ, Citiuscomm, Apto.AI, SaleskenSupporting Association – Indian Society of Artificial Intelligence and LawOfficial Event Tech Partner – KONFHUBOfficial Print Partner – Business StandardAbout TresconTrescon is a pioneering force in the global business events and services sector, driving the adoption of emerging technologies while promoting sustainability and inclusive leadership. With a deep understanding of the realities and requirements of the growth markets we operate in – we strive to deliver innovative and high-quality business platforms for our clients. For more information about Trescon, visit: www.tresconglobal.comFor media inquiries and further information, please contact:Vishal S SMedia and Communications SpecialistTresconEmail: vishals@tresconglobal.comMobile: +91-7358680951 Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

JAKARTA, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - Realising yet another milestone, TransNusa has signed agreements with Sunway Medical Centre and Asia OneHealthCare with the aim to provide its passengers with additional healthcare options and thus, expanding its operations into the Medical Tourism Industry.TransNusa recently inked agreements with three medical centres allowing its passengers to enjoy additional privileges in the medical centres. The medical centres are Sunway Medical Centre, Subang Jaya Medical Centre and Ara Damansara Medical Centre. Subang Jaya Medical Centre and Ara Damansara Medical Centre are owned by Asia OneHealthCare.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said, “We feel privileged to be able to expand our service offerings to include healthcare. Our Passengers will be eligible to purchase specialised and customised healthcare packages at three renowned medical centres in Malaysia.“TransNusa’ passengers can now enjoy two Signature Elite Health Screening Package, which is valued at RM1500 (USD348) at RM750 (Estimated USD174) at Sunway Medical Centre. The package price is being offered at a 50 per cent discount for TransNusa’ passenger. In addition to the discount, passengers will be able to enjoy free seat upgrades.  “In order to be eligible for the above package, our passengers will need to showcase their boarding passes when registering for the package at Sunway Medical Centre,” explained Datuk Francis.“Passengers who fly TransNusa will also be able to enjoy a 20 per cent discount for all medical check-up at Subang Jaya Medical Centre and Ara Damansara Medical Centre,” Datuk Francis continued, adding that passengers will also be able to enjoy free airport transfer from the Subang Airport to the Subang Jaya Medical Centre and Ara Damansara Medical Centre.LEADING TRANSNUSA TO GREATER HEIGHTS... Datuk Bernard Francis, Chief Executive Officer, TransNusaAll three medical centres are close to Subang Airport, with Ara Damansara Medical Centre being the closest. The medical centre is only 7.9km from the Subang Airport, which is also known as the Sultan Abdul Aziz Shah Airport. Meanwhile, Sunway Medical Centre is 14 km from the airport and Subang Jaya Medical Centre is 13km from the airport.TransNusa will be operating one daily scheduled flight from Terminal 3, Soekarno-Hatta International Airport to Subang Airport. The flight, 8B 699, will depart Jakarta at 04.10pm and arrive at the Subang Airport at 07.00pm while TransNusa flight, 8B 698, will depart Subang Airport at 07.30pm and arrive in Jakarta at 08.30pm. TransNusa will be utilizing its A320 narrow-body airliner, which has 174 seats, to cater for the two-hour scheduled flight. TransNusa ticket for this route is competitively priced from RM240 (Estimated USD54).TransNusa, which had to close it business operation in September 2020 due to impact of the Covid-19 pandemic on the aviation industry, started operations again after injection of new shareholders and management team led by Malaysian-born aviation industry veteran, Datuk Bernard Francis, in October 2022.Within 6 months, under the leadership of Datuk Francis, the airline introduced its first international route between Jakarta and Kuala Lumpur and celebrated its first-year anniversary for this route on April 14, 2024.Since the change in management team, TransNusa has been contributing and changing the aviation landscape in Indonesia. It has been making headlines in Indonesia, Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia and the world to develop and introduce a new domestic route connecting Bali and Manado. TransNusa also became the second Indonesian airline to receive approval to fly to China and provided its passengers with more pricing and route options to China. In addition, the airline also became the first airline outside China to utilise the COMAC ARJ21-700.Primary Media ContactTrina Thomas Raj+6012 499 2672trina@myqaseh.orgAbout TransNusaTransNusa Airline is a Premium Service Carrier. After the take-over in February 2024, the airline rebranded itself from being a Low-Cost Carrier to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered.TransNusa, which received its AOC certification on 9th September 2022, launched its first three A320 operations on 6th October, 14th October and 12th December, 2022. The airline, which became the first outside of China to utilise Comac, received its first ARJ21 on 22nd December, 2022.  In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently based in Jakarta Soekarno-Hatta International Airport.The airline currently flies to Yogyakarta and Bali. On the international front, TransNusa flies to Singapore, Guangzhou, Kuala Lumpur and Johor. The airline became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model.Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore, Malaysia and Indonesia, or by contacting the airline's customer service centre at +6221 631 0888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd on +65 8660 2719, while for the Malaysian market passengers can contact MKM Ticketing Travel & Tours Sdn Bhd on +6037 831 2581. Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

BANGKOK, Oct 22, 2024 - (ACN Newswire via SeaPRwire.com) - T.MAN Pharmaceutical PCL (SET: TMAN), a leader in the production and distribution of pharmaceuticals and healthcare products in Thailand for over 50 years, debuts on the Stock Exchange of Thailand (SET) under the Personal Products & Pharmaceuticals sector. The company has showcased its commitment to investing in technology to enhance production and efficiency, focusing on the research, development, and innovation of pharmaceuticals and healthcare products. Aiming to expand its market presence both domestically and internationally, the company strives to be a leader in health innovation that enhances the quality of life for all.Mr. Prapon Thanachotipan, Chief Executive Officer of T.MAN Pharmaceutical PCL ("the company" or "TMAN"), announces that the company starts trading its shares on the SET on October 22, 2024, under the consumer products industry group, specifically in the personal products and pharmaceuticals category, using the ticker symbol “TMAN”. He expresses confidence that the company’s strong foundation in health innovation, from research and development of pharmaceuticals and healthcare products to enhancing production standards with modern technology and effective marketing strategies, will make TMAN a quality stock that attracts investors. The company aims to be a leader in health innovation, helping to improve the quality of life for everyone.Following its listing, the company has allocated a short-to-medium-term investment budget not exceeding 777.5 million THB, divided as follows:1) Ongoing projects involving construction and machinery installation, totaling up to 298.5 million THB. These include:1.1) Projects to improve the efficiency of herbal product manufacturing,1.2) Projects to enhance the efficiency of modern medicine production,1.3) Expansion of research and development,1.4) Increased production capacity for dietary supplements,1.5) Development of sales systems using information technology,1.6) Procurement of quality control equipment for modern medicine,1.7) Procurement of quality control equipment for dietary supplements, and1.8) Construction of warehouses and office buildings, with several projects already underway.2) The company has also planned future investments for business expansion in 5 projects, with a budget not exceeding 479.0 million THB. These include:2.1) Construction of a new headquarters building,2.2) The first phase of expanding production capacity for modern medicine,2.3) Investment in the installation of solar panels (Solar Rooftop),2.4) Upgrading production areas for modern medicine, and2.5) The second phase of expanding production capacity for modern medicine.Mr. Prapon states that after being listed on the stock exchange, the company has strategized for sustainable growth by focusing on building brand recognition and acceptance for its products. It aims to develop pharmaceuticals for chronic non-communicable diseases (NCDs) and respiratory conditions to expand its customer base among hospitals, a major segment in the pharmaceutical industry. Currently, the company has over 226 brands. Additionally, it will continue to research and develop diverse and high-quality health innovations to fully meet customer needs. The company also plans to increase its contract manufacturing (OEM/ODM) and distribution services, while boosting revenue growth by expanding product distribution to over 22 countries worldwide, aiming to become a global brand in the future.Mr. Thinnaphan Wanglee, Deputy Managing Director of Kasikorn Securities Public Company Limited, acting as the financial advisor and lead underwriter, states that TMAN is a leading group in the production and distribution of pharmaceuticals and health products in Thailand. It is at the forefront of inventing, researching, and developing pharmaceuticals and healthcare products that fit current trends in preventive and therapeutic healthcare. TMAN has enhanced its R&D centers and production facilities with modern technology, improving its competitiveness as well as aggressively expanding its business both domestically and internationally, driven by strong business strategies that will enable sustainable growth.Analysts from leading securities firms view TMAN shares as having a solid foundation, with a diverse range of over 842 SKUs in pharmaceuticals and healthcare products, many of which are popular in the market with strong brand presence. The company plans to launch 10-12 new products annually, backed by research and development that swiftly addresses consumer needs. Strategies to expand its customer base among hospitals and penetrate international markets are expected to drive continuous sales growth both domestically and abroad. Effective cost management through direct distribution to customers also contributes to its growth. Analysts have assessed the fundamental value of TMAN shares to be in the range of 24.0-29.5 THB per share, with a positive outlook driven by the following factors: 1) Expanding product lines under existing brands, 2) Launching new products under the TMAN brand, 3) Expanding the customer base among hospitals, 4) Continuously growing distribution channels, and 5) Boosting international sales to move towards becoming a global brand.Additionally, TMAN engages in third-party distribution, which provides in-depth market and consumer behavior insights that support the company's growth. The current consumer trend toward health consciousness, which is a global megatrend, further drives this growth.Released by Public Relations Dept, MT Multimedia Co., Ltd for T.MAN Pharmaceutical PCL or TMANFor more information, please contact: Pipop (Top)Tel. +66 81-929-8864; Email: pipop.k@mtmultimedia.com T.MAN Pharmaceutical PCL [SET: TMAN; TMAN/F; TMAN-R] https://www.tmanpharma.in.th/en/home-en/  Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

KUALA LUMPUR, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - BlackBerry Limited (NYSE:BB)(TSX:BB) has announced a new partnership with The International Information System Security Certification Consortium (ISC2), the world's leading nonprofit member organization for cybersecurity professionals, to deliver its globally recognized cybersecurity training and certifications in Malaysia. In support of the Malaysian Government's ongoing efforts to boost digital skills, capacity and cyber-resilience, the courses are now offered as part of the BlackBerry Cybersecurity Curriculum at the world-class Cybersecurity Center of Excellence (CCoE) facility in Cyberjaya. Registration is now open for the first ISC2 courses taking place later this month.As Malaysia's digital transformation continues to accelerate and threat surfaces expand, so too does the demand for highly-qualified cybersecurity professionals. BlackBerry's new partnership with ISC2 extends the range of internationally-certified courses available to cyber professionals at the Malaysia CCoE to help upskill and enhance capabilities to bolster defenses against ever-evolving cyber threats. The courses include ISC2's highly sought-after Certified Information Systems Security Professionals (CISSP), Certified Cloud Security Professional (CCSP) and Certified in Cybersecurity (CC).Han Ther Lee, Director of Education and Training, Cybersecurity Center of Excellence, BlackBerry, commented, "As Malaysia prepares for the ‘Year of Skills' in 2025, BlackBerry remains committed to collaborating with government and industry to help educate, upskill and grow the nation's cyber-workforce. We are proud to partner with another top-tier training institution like ISC2, further enriching the curriculum offered at the Cybersecurity Center of Excellence and giving cyber professionals in Malaysia and the region wider access to globally recognized certifications."The first courses offered through the partnership will focus on critical cybersecurity disciplines, including security operations, risk management, and cloud security, vital to strengthening national and regional cybersecurity capabilities, especially as the region pushes forward its digital transformation goals. ISC2 will provide comprehensive training materials, course resources, licenses, and ongoing support for all its programs.Cigdem Bildirici​​​​, Vice President, Business Development, ISC2 added, "With Malaysia advancing towards a more digitally connected future and the accompanying rise in cyber risks, strengthening the cybersecurity workforce has become more vital than ever. We're excited to collaborate with BlackBerry at the Cybersecurity Center of Excellence to bring our training programs to support this growth."Since opening the CCoE in March 2024, with the support of the Malaysian Communications and Multimedia Commission (MCMC), BlackBerry and its education partners have dedicated over 8,000 hours to train over 1,500 professionals at the facility. Several education partnerships also offer globally-certified training courses at the CCoE, including CompTIA, SANS Institute and the Rogers Cybersecure Catalyst ("the Catalyst") at Toronto Metropolitan University, which runs its CLIC (Certifications of Leadership in Cybersecurity) training program.Now in its sixth month of operations, the addition of ISC2 training programs at the CCoE is another milestone achievement for the non-profit institution, which aims to provide the most comprehensive set of certifications and training courses available in the Indo-Pacific region.The first wave of ISC2 certification courses, Certified in Cybersecurity (CC) will commence by the end of October 2024, while the renowned CISSP and CCSP programs, will start in November 2024. Cybersecurity professionals and organizations across Malaysia and the Indo-Pacific region can now register for the ISC2 courses here. Additional programs, such as specialized workshops and advanced training, will be rolled out in the months to follow, providing continuous opportunities for upskilling and certification.About ISC2ISC2 is the world's leading member organization for cybersecurity professionals, driven by our vision of a safe and secure cyber world. Our nearly 675,000 members, candidates and associates around the globe are a force for good, safeguarding the way we live. Our award-winning certifications - including cybersecurity's premier certification, the CISSP® - enable professionals to demonstrate their knowledge, skills and abilities at every stage of their careers. ISC2 strengthens the influence, diversity and vitality of the cybersecurity profession through advocacy, expertise and workforce empowerment that accelerates cyber safety and security in an interconnected world. Our charitable foundation, The Center for Cyber Safety and Education, helps create more access to cyber careers and educate those most vulnerable. Learn more and get involved at ISC2.org. Connect with us on X, Facebook and LinkedIn.© 2024 ISC2 Inc., ISC2, CISSP, SSCP, CCSP, CGRC, CSSLP, HCISPP, ISSAP, ISSEP, ISSMP, CC, and CBK are registered marks of ISC2, Inc.About BlackBerryBlackBerry (NYSE:BB)(TSX:BB) provides intelligent security software and services to enterprises and governments around the world. The company's software powers over 235M vehicles. Based in Waterloo, Ontario, the company leverages AI and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy, and is a leader in the areas of endpoint security management, encryption, and embedded systems. BlackBerry's vision is clear - to secure a connected future you can trust.BlackBerry. Intelligent Security. Everywhere.For more information, visit BlackBerry.com and follow @BlackBerry.Media Contact:BlackBerry Media Relations+1 (519) 597-7273mediarelations@blackBerry.comSOURCE: BlackBerry Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

SINGAPORE, Oct 22, 2024 - (ACN Newswire via SeaPRwire.com) - ONERHT Foundation Ltd, the corporate social responsibility arm of RHTLaw Asia LLP and the RHT Group of Companies (“ONERHT”), successfully raised more than S$430,000 at its 9th charity golf and gala dinner event. The funds will be directed towards the Foundation’s key initiatives, including the Ageing RigHT Project and other community programmes aimed at supporting Singapore’s ageing population and diverse community needs.Ms Evelyn Chng, Director of ONERHT Foundation, Mr Bernard Tay, Director of ONERHT Foundation, Mr Ho Peng Kee, Patron of ONERHT Foundation, Mr Tan Chong Huat, Senior Partner of RHTLaw Asia, Ms Kaylee Kwok, Chairman and Director of ONERHT Foundation, Guest-of-Honour, Deputy Prime Minister and Minister for Trade and Industry Mr Gan Kim Yong, Mr Yang Eu Jin, Director of ONERHT Foundation, Mr Azman Jaafar, Managing Partner of RHTLaw Asia at the ONERHT Charity Golf 2024 Gala Dinner. [L-R]The gala dinner, held on 18 October 2024 at Sentosa Golf Club, was honoured by the presence of Guest-of-Honour, Deputy Prime Minister and Minister for Trade and Industry Mr Gan Kim Yong. The event successfully brought together more than 200 participants, including golfers and distinguished guests from various industry sectors.This year, to mark its 9th edition of the charity golf and gala dinner event, the Foundation has pledged to support a total of 9 beneficiaries. The beneficiaries are PAP Community Foundation Sparkle Care Centres, Life Community Services Society, Singapore Cancer Society, Singapore Road Safety Council, Bethel Community Services, Singapore Christian Home, South Central Community Family Service Centre, Focus on the Family Singapore Limited and Intercultural Theatre Institute. This demonstrates the Foundation’s commitment to reach out to a wider range of charities and support more beneficiaries.Ms Kaylee Kwok, Chairman of ONERHT Foundation, emphasised the importance of the Foundation’s work: “We are profoundly grateful for the generosity of our donors and sponsors, whose unwavering support propels our mission at ONERHT Foundation. Together, we are making significant strides towards fostering positive change within our community. We remain steadfast in our commitment to our core focus areas: education, environmental and sustainability, disadvantaged groups, and the arts and sports.”The donations made to various charitable organisations will enhance their programmes and services, allowing them to better serve their communities. This commitment to supporting a diverse range of individuals highlights the importance of community-driven initiatives that make a positive impact on the lives of those in need, such as empowering youth, caring for seniors, mentoring families, and providing comprehensive healthcare services, and much more.Ms Lam Moi Kwai, CEO of Life Community Services Society, shared her gratitude. “We extend our heartfelt gratitude to the ONERHT Foundation for their generous support over the years. The Foundation’s contributions play a vital role in empowering our LCSS beneficiaries, enabling us to provide essential care and mentoring to children and families in need. We thank the Foundation for being an invaluable partner in our mission."Ms Delia Ng, CEO, Focus on the Family Singapore, also said, “Thank you ONERHT Foundation for your generous support which would enable us to expand our outreach and equipping efforts for youths who aspire to become family champions through our FamChamps movement. Youths will be inspired in hope and empowered with the necessary mindset and resilience to break cycles of dysfunction and adversity.”Mr Victor Bay, CEO of PAP Community Foundation, shared, “PCF Sparkle Care is grateful for the support from ONERHT Foundation all these years. Their generous donation has enabled us to continue to provide programmes and care to the seniors whom we are so privileged to serve.”Similarly, Mr Albert Ching, CEO, Singapore Cancer Society, said, "The Singapore Cancer Society is honoured to have ONERHT Foundation join us in the collective fight against cancer. With the number of people living with cancer on the rise, the Foundation’s generous support strengthens our efforts to provide comprehensive cancer care services to beneficiaries at every stage of their journey. This includes free cancer screenings, welfare, rehabilitation support, hospice care, and public education initiatives. Thank you, ONERHT Foundation, for helping us minimise cancer and maximise lives!”Since its establishment in 2015, ONERHT Foundation has raised over S$5 million for more than 30 beneficiaries, demonstrating its commitment to fostering a more inclusive and supportive community in Singapore.ONERHT Foundation LtdA Singapore registered charity and grant-making philanthropic organisation, ONERHT Foundation Ltd (“Foundation”) enables RHTLaw Asia LLP and the RHT Group of Companies (collectively, “ONERHT”) to do right and do good through various charitable endeavours.Set up by ONERHT in 2015, the Foundation was registered as a Singapore charity by the Commissioner of Charities and a grant-making philanthropic organisation by the Inland Revenue Authority of Singapore on 16 September 2016 and 28 November 2016 respectively.The Foundation seeks to establish, inspire and encourage the right philanthropic culture among the corporate and legal fraternity of giving back to the community in a focused, hands-on and meaningful manner. Since its inception, the Foundation has raised over S$5 million to support more than 30 beneficiaries involved in education, the environment and sustainability, disadvantaged groups as well as the arts and sports.For more information, please visit www.onerht.foundationFor media enquiries, please contact:Elliot Siow / elliot@waterbrooks.com.sg / +65 8375 0417 Copyright 2024 ACN Newswire via SeaPRwire.com.

megan 23 10 月, 2024

MELBOURNE, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - In recognition of Breast Cancer Awareness Week, George Stamas, AM, Director of GJK Facility Services, organized a nationwide educational session featuring renowned breast cancer surgeon Dr. Chantel Thornton. This initiative aimed to raise awareness about the importance of early detection and regular breast cancer screenings.Dr. Chantel Thornton, Specialist Breast Cancer SurgeryDr. Thornton engaged with the GJK team in a live-streamed session, providing valuable insights and practical advice to employees across the country. She emphasized the critical role of early detection and prevention in effectively combating breast cancer. Dr. Thornton demonstrated self-examination techniques and stressed that regular checks significantly enhance the chances of early detection, which is key to successful treatment outcomes.This educational session not only raised awareness but also empowered participants with actionable knowledge to prioritize their health and well-being. It reflects GJK Facility Services' commitment to fostering a supportive workplace that values employee wellness.George Stamas is passionately committed to supporting the fight against breast cancer. His contributions include helping to secure funding for the second Trident Imaging System, a portable xâ€?ray machine that is used during breast cancer surgery to help determine whether all the tumour cells have been removed.By prioritizing employee health and promoting early detection, GJK Facility Services demonstrates its dedication to creating a positive work environment that values the well-being of its team and their families.Dr. Chantel Thornton Specialist Breast Cancer Surgery MelbourneDr. Chantel Thornton is a Specialist Breast Cancer Surgeon utilising oncoplastic techniques who is passionate about delivering the highest standard of multidisciplinary care for patients with breast cancer. She has a special interest in the surgical management of young women with breast cancer and achieving the best oncological and cosmetic outcome and endorses immediate breast reconstruction post-mastectomy.Dr. Thornton completed a Bachelor of Medicine and Bachelor of Surgery with first-class honours from the University of Tasmania in the year 2000 and was dux of her medical school and received eight university prizes. She also has a Bachelor of Medical Science with honours, which was undertaken at The University of Hong Kong. In 2010, Dr. Thornton was awarded a fellowship from the Royal Australasian College of Surgeons. She completed fellowship training in breast cancer surgery at the Peter MacCallum Cancer Centre.Dr. Thornton is a fellow of the Australian Institute of Company Directors and has served on numerous philanthropic boards including the Alfred Hospital Foundation, the Foundation for Surgery and the Foundation for Breast Cancer Care. She is past chair of the Life Support Committee and member of the Epworth Special Events Committee.Dr. Thornton is founder and director of Specialist Breast Cancer Surgery and Specialist Cosmetic Centre. She established this purpose-built women's health centre with a dedicated team to enhance the treatment of patients with breast cancer. The centre aims to provide holistic care and improve the medical and psychological wellbeing of patients while delivering the very best breast cancer care.Contact InformationMedia Relations GJK Facility ServicesMediainfo@gjkfacilityservices.com.au1800635983Related ImagesDr. Chantel Thornton, Specialist Breast Cancer SurgeryDr. Chantel Thornton Presenting at GJK Facility ServicesDuring Breast Cancer Awareness Week, Dr. Chantel Thornton presented to GJK Facility Staff across Australia.Kaye, a Breast Cancer Survivor, Explaining Early DetectionSOURCE: GJK Facility Services Copyright 2024 ACN Newswire via SeaPRwire.com.